RANDOMIZED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION

被引:773
|
作者
VERSTRAETE, M
BORY, M
COLLEN, D
ERBEL, R
LENNANE, RJ
MATHEY, D
MICHELS, HR
SCHARTL, M
UEBIS, R
BERNARD, R
BROWER, RW
DEBONO, DP
HUHMANN, W
LUBSEN, J
MEYER, J
RUTSCH, W
SCHMIDT, W
VONESSEN, R
机构
来源
LANCET | 1985年 / 1卷 / 8433期
关键词
D O I
10.1016/S0140-6736(85)92208-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:842 / 847
页数:6
相关论文
共 50 条
  • [22] IMPROVED LEFT-VENTRICULAR FUNCTION FOLLOWING INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    JOHNS, JA
    YASUDA, T
    GARABEDIAN, HD
    AARONSON, RA
    LEINBACH, RC
    AKINS, CW
    GOLD, HK
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : A190 - A190
  • [23] INTRAVENOUS THROMBOLYTIC THERAPY WITH A COMBINATION OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    BODE, C
    SCHULER, G
    NORDT, T
    SCHONERMARK, S
    BAUMANN, H
    RICHARDT, G
    DIETZ, R
    GUREWICH, V
    KUBLER, W
    CIRCULATION, 1990, 81 (03) : 907 - 913
  • [24] EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX ON MORTALITY IN ACUTE MYOCARDIAL-INFARCTION
    HELD, PH
    TEO, KK
    YUSUF, S
    CIRCULATION, 1990, 82 (05) : 1668 - 1674
  • [25] INTRAVENOUS BOLUS ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR TO PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    TRANCHESI, B
    VERSTRAETE, M
    VANHOVE, P
    VANDEWERF, F
    CHAMONE, DF
    BELLOTTI, G
    PILEGGI, F
    CORONARY ARTERY DISEASE, 1990, 1 (01) : 83 - 88
  • [26] STREPTOKINASE AND TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    BREWER, CC
    MARKIS, JE
    HEART & LUNG, 1986, 15 (06): : 552 - 558
  • [27] EFFECTIVENESS AND SAFETY OF A SINGLE INTRAVENOUS BOLUS INJECTION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    HACKETT, D
    ANDREOTTI, F
    HAIDER, AW
    BRUNELLI, C
    SHAHI, M
    FUSSELL, A
    BULLER, N
    FOALE, R
    LIPKIN, D
    CAPONNETTO, S
    DAVIES, G
    MASERI, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (17): : 1393 - 1398
  • [28] FINAL REPORT OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND EMERGENCY CORONARY ANGIOPLASTY THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
    TOPOL, EJ
    ONEILL, WW
    LANGBURD, AB
    BATES, ER
    BOURDILLON, PDV
    WALTON, JA
    GRINES, CL
    KLINE, E
    PITT, B
    CIRCULATION, 1986, 74 (04) : 22 - 22
  • [29] A RANDOMIZED COMPARISON OF INTRAVENOUS HEPARIN WITH ORAL ASPIRIN AND DIPYRIDAMOLE 24 HOURS AFTER RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION
    THOMPSON, PL
    AYLWARD, PE
    FEDERMAN, J
    GILES, RW
    HARRIS, PJ
    HODGE, RL
    NELSON, GIC
    THOMSON, A
    TONKIN, AM
    WALSH, WF
    CIRCULATION, 1991, 83 (05) : 1534 - 1542
  • [30] A RANDOMIZED TRIAL OF IMMEDIATE VERSUS DELAYED ELECTIVE ANGIOPLASTY AFTER INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
    TOPOL, EJ
    CALIFF, RM
    GEORGE, BS
    KEREIAKES, DJ
    ABBOTTSMITH, CW
    CANDELA, RJ
    LEE, KL
    PITT, B
    STACK, RS
    ONEILL, WW
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (10): : 581 - 588